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Background:  In-hospital bleeding is associated with subsequent mortality and morbidity in patients with AMI. However, the effect of in-hospital 
bleeding on the long-term prognosis has not been reported.
Methods:  Primary PCI was performed in 3345 (92.9%) of 3602 randomized pts, 231 (6.9%) of whom developed in-hospital protocol-defined 
non-CABG related major bleeding in HORIZONS-AMI trial. We compared MACEs (composite of death, reinfarction, stroke or ischemic TVR), each 
component of MACEs and stent thrombosis (ST) at 3-yr follow-up according to the presence of bleeding events.
Results:  Patients with bleeding were older, more often female, diabetic and hypotensive.They used abciximab more frequently. In the analysis of 
clinical outcomes, hemorrhagic patients showed higher MACEs (43.7% vs. 20.5%, p<0.0001) at 3-yr follow-up (Figure). They had more death (23.7% 
vs. 5.4%, p<0.0001), cardiac death (13.8% vs.3.2%, p<0.0001), reinfarction (11.2% vs. 7.1%, p=0.018), stroke (5.0% vs. 1.4%, p<0.0001) and 
ischemic TVR (19.9% vs. 13.4%, p=0.0035). ST (definite or probable) was also more frequent in patients with bleeding (10.9% vs. 4.7%, p<0.0001). 
However, there was no difference in very late ST (1.3% vs. 0.6%, p=0.31).
Conclusions:  The detrimental effects of in-hospital major bleeding on clinical outcomes were maintained up to 3 years in patients 
with AMI. Further studies are warranted to identify patients with risk of bleeding and to manage them with tailored approach. 
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